According to a new trial, patients with chronic lymphocytic leukemia (CLL) show comparable outcomes whether they receive a single-agent treatment indefinitely or a combination treatment for a fixed period of time.
To continue reading click here
Fixed-duration therapy works as effectively as continuous treatment for chronic lymphocytic leukemia
